October 5th in Drugs by Vivian Goldschmidt, MA .
As it relates to osteoporosis news, this past September will be one to remember. In response to a growing number of reported adverse effects linked to bisphosphonates – the most commonly prescribed osteoporosis drugs such as Fosamax, Actonel, and Boniva, to name a few – an FDA advisory …
September 22nd in Drugs by Vivian Goldschmidt, MA .
They say that numbers don’t lie. So when statistics clearly show that for the first time ever in the U.S.A. prescription drugs have killed more people than car accidents, even the CDC is forced to face the sad truth.
The numbers reported just a couple of days ago by ABC …
September 5th in Drugs by Vivian Goldschmidt, MA .
As I write in a recent blog post titled ‘Alert: New Life-Threatening Reclast Side Effects’, the most commonly reported Reclast side effects – ranging from joint and bone pain to osteonecrosis of the jaw – pale in comparison to the most recent concerns regarding kidney impairment and failure.
In the …
March 30th in Drugs by Vivian Goldschmidt, MA .
Acid reflux drugs increase risk of fractures. Such is the title of an article published just a few days ago. Considered as “breakthrough” news, I have been warning of the very same problem in the Save Our Bones Program for years.
This is just further evidence of how the Save Our …
March 13th in Drugs by Vivian Goldschmidt, MA .
US consumer advocacy groups are up in arms. New and devastating Reclast side effects led these groups to demand that new warnings be placed on the drug’s label.
As I wrote in my Reclast review, the most commonly reported Reclast side effects are fever, muscle, joint and bone pain, flu-like …
March 9th in Drugs by Vivian Goldschmidt, MA .
Atelvia (risedronate sodium), an oral bisphophonate made by Warner Chilcott, has been approved in the US on October 8, 2010. Here’s the simple trick used for creating Atelvia: clever marketing sleight of hand.
Let me explain.
Atelvia’s active ingredient is identical to its twin Actonel, and similar to its cousins Fosamax …
February 6th in Drugs by Vivian Goldschmidt, MA .
Let’s face it. When news breaks of an osteoporosis drug discovery that increases bone strength and reduces fractures in the hip, spine, wrist, leg, and rib, the medical establishment listens… and prescribes.
Add to this the convenience of a once-yearly 15 minute intravenous infusion, and it seems like an osteoporosis treatment …
January 30th in Drugs by Vivian Goldschmidt, MA .
I’ve answered several questions about strontium as part of my Vivian Answers Day series. But I’ve noticed that more strontium related questions keep coming, so I’ve decided to compile all the information about strontium in one place to serve as a handy reference for you …
September 8th in Drugs by Vivian Goldschmidt, MA .
Once again bisphosphonates, the most widely prescribed osteoporosis drugs, are linked to a dangerous condition. This time, it’s cancer of the esophagus, one of the deadliest cancers.
Not long after a recent flurry of reports on atypical femur fractures observed by long-term bisphophonate use, a new study in the UK …
July 14th in Drugs by Vivian Goldschmidt, MA .
This past June 1st, the FDA approved Prolia ™ (denosumab), a brand new twice-yearly injectable osteoporosis drug by Amgen.
The first drug of its kind, Prolia was designed to treat and prevent postmenopausal osteoporosis for patients considered to be at high risk of fractures. It’s also marketed as an alternative …